News, /

The members of the European Patient Group on Antimicrobial Resistance (AMR Patient Group), are truly committed to raising awareness about the real-world impact of antimicrobial resistance (AMR) and healthcare-associated infections (HAIs). Consequently, we strive to help reduce the inappropriate use of existing antibiotics, promote antimicrobial stewardship and infection prevention and control measures across Europe, and develop novel antibiotics where needed.

The European AMR Patient Group has developed a pan-European survey to assess the level of knowledge and awareness of antimicrobial resistance (AMR) and health-associated infections (HAIs) among 5 European countries, namely Italy, France, Germany, Spain and the UK. 

The survey has close-ended questions and it will take only 15 minutes to be completed.

The overarching objective of this questionnaire is to arm all European citizens with the necessary knowledge about antimicrobial resistance and healthcare-associated infections to ensure the appropriate use of antibiotics as well as the knowledge of other existing tools that can prevent, monitor, detect and diagnose infections.

The AMR Patient Group kindly invites you to reply to and increase participation in the survey among your network. Although voluntary, the participation of patient representatives based in the afore-mentioned countries will be highly appreciated and will enrich the results in a meaningful way.

Please find the links to fill in the survey as follows

Kindly note that all contributions to this survey will be treated anonymously and in full compliance with the GDPR.

It is now more urgent than ever to step up actions to prevent HAIs and the related development of AMR throughout the patient journey.

To learn more, please find our 2021 Declaration on AMR and infographics here.